Cargando…
MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Expression of Concern]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359789/ https://www.ncbi.nlm.nih.gov/pubmed/35958055 http://dx.doi.org/10.2147/OTT.S384667 |
Ejemplares similares
-
MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin
por: Yin, Zhaojun, et al.
Publicado: (2019) -
MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Retraction]
Publicado: (2023) -
Expression of Concern: microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer
Publicado: (2020) -
Expression of Concern: MicroRNA-505-5p functions as a tumor suppressor by targeting Cyclin-Dependent Kinase 5 in cervical cancer
Publicado: (2020) -
Expression of Concern: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Publicado: (2022)